Liminal is a biotechnology company that develops novel small molecule compounds to treat respiratory, liver and renal diseases... Read more
Liminal is a biotechnology company that develops novel small molecule compounds to treat respiratory, liver and renal diseases... Read more
News
Sep 26, 2023
BioSpace
Liminal BioSciences: Liminal Biosciences Announces Completion of the Plan of Arrangement With Structured Alpha LP
Sep 26, 2023
MarketScreener
Liminal BioSciences: Liminal BioSciences : Notice
Sep 12, 2023
BioSpace
Liminal BioSciences: LIMINAL BIOSCIENCES FILES AMENDED SCHEDULE 13E-3 AND SUPPLEMENT TO THE MANAGEMENT INFORMATION CIRCULAR
Aug 17, 2023
MarketScreener
Liminal BioSciences: Liminal BioSciences : Notice of Special Meeting of Shareholders and Management Information Circular dated August 16, 2023 - Form 6-K
Aug 16, 2023
FinanzNachrichten
Liminal BioSciences: Liminal BioSciences Inc.: LIMINAL BIOSCIENCES OBTAINS INTERIM ORDER FOR PROPOSED ARRANGEMENT WITH STRUCTURED ALPHA LP
Aug 08, 2023
FinanzNachrichten
Liminal BioSciences: Liminal BioSciences Inc.: Liminal BioSciences Reports Second Quarter Financial Results 2023
Jul 12, 2023
BioSpace
Liminal BioSciences: Liminal BioSciences Announces Arrangement Agreement with Structured Alpha LP
Jun 05, 2023
MarketScreener
Liminal BioSciences: Liminal BioSciences Announces Voting Results of its 2023 Annual General Meeting of Shareholders
Jun 02, 2023
Canadian Manufacturing
Liminal BioSciences: Liminal BioSciences provides R&D update
May 09, 2023
FinanzNachrichten
Liminal BioSciences: Liminal BioSciences Inc.: Liminal BioSciences Reports First Quarter Financial Results 2023
